Halder exits Klingel medical metal


Transformation to dedicated medtech specialist completed

Halder Beteiligungsberatung GmbH has signed an
agreement to sell its investment in Klingel medical metal, Pforzheim/Germany, to IK Investment Partners. Klingel has been a Halder portfolio company since 2012, financial details of the transaction are not disclosed.

Klingel medical metal was established in 1986. The company specialises in customer specific micro-machined precision parts made from high-quality steels and titanium. In 2012, revenues were € 23.6 million, about 50% of the total were related to medtech clients. Over the following years, Klingel has become a successful supplier to the medtech industry by focusing its business model on the industry, an extensive rebranding project and a pro-active go-to-market approach. The new strategy was supported by some € 15 million in capital expenditure for more capacity and extensions of the firm’s value chain as prototyping, automatic cleaning and electro-polishing were added. By the end 2017, revenues had risen to € 36.5 million, driven by organic growth and the acquisition of Josef Ganter Feinmechanik in 2016. Over the same period, revenue contributions from medtech clients grew to 70%; staff increased from 200 to more than 300.

Halder has been active in Germany since 1991 and has provided 38 SMEs with capital for ownership succession and growth. Portfolio companies grow by internationalisation, focusing their strategy and business model, comprehensive capital expenditure and add-on investments. Klingel is the second exit from the Halder Germany II fund.